Both oral and injectable tirzepatide carry similar systemic side effect profilesnausea, vomiting, diarrhea, and constipation occur with both routes
Together, they engage two separate hormonal systems that both regulate body weight creating an additive, and potentially synergistic, effect on appetite suppression and calorie reduction
Patients with certain GLP1R variants may achieve therapeutic benefit at lower doses, while others require higher exposure for equivalent weight lossand mismatched dosing in either direction increases overdose or inefficacy risk
But doctors also have the power to prescribe the medicine off-label for reasons other than indicated on the package insert, which, in this case, is to help heavily overweight or obese people lose weight
Patients receive ongoing monitoring and unlimited messaging access to licensed physicians for safe and effective treatment support